Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin B Carlin

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Langmuir : the ACS Journal of Surfaces and Colloids|August 5, 2016
Targeted Mutagenesis and Combinatorial Library Screening Enables Control of Protein Orientation on Surfaces and Increased Activity of Adsorbed ProteinsCarlos A Cruz-Teran, Kevin B Carlin, Kirill Efimenko, et al.
ACS Synthetic Biology|June 9, 2016
Combinatorial Pairwise Assembly Efficiently Generates High Affinity Binders and Enables a "Mix-and-Read" Detection SchemeKevin B Carlin, Carlos A Cruz-Teran, Jay Prakash Kumar, et al.
Experimental Hematology|September 16, 2025
An engineered IgM antibody targeting CD20 has enhanced complement-dependent cytotoxicity compared with an IgGKevin C Hart, Paul R Hinton, Marigold Manlusoc, et al.
Nature|June 3, 2021
Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variantsZhiqiang Ku, Xuping Xie, Paul R Hinton, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Langmuir : the ACS Journal of Surfaces and Colloids|August 5, 2016
Targeted Mutagenesis and Combinatorial Library Screening Enables Control of Protein Orientation on Surfaces and Increased Activity of Adsorbed ProteinsCarlos A Cruz-Teran, Kevin B Carlin, Kirill Efimenko, et al.
ACS Synthetic Biology|June 9, 2016
Combinatorial Pairwise Assembly Efficiently Generates High Affinity Binders and Enables a "Mix-and-Read" Detection SchemeKevin B Carlin, Carlos A Cruz-Teran, Jay Prakash Kumar, et al.
Experimental Hematology|September 16, 2025
An engineered IgM antibody targeting CD20 has enhanced complement-dependent cytotoxicity compared with an IgGKevin C Hart, Paul R Hinton, Marigold Manlusoc, et al.
Nature|June 3, 2021
Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variantsZhiqiang Ku, Xuping Xie, Paul R Hinton, et al.
Pageof 1